comparison of glp-1 agonists GLP-1-based therapies: current knowledge differences between native What are GLP-1 Receptor Agonists?
Description
95% CI, 1.15 to 1.26) and diabetic macular edema (HR, 1.13

Wadden TA, Brown GK, Egebjerg C, Frenkel O, Goldman B, Kushner RF, et al

T2DM, type 2 diabetes mellitus

doi: 10.1111/jdi.12275 75 NauckMRizzoMJohnsonABosch-TrabergHMadsenJCariouB

Treatment of HFpEF beyond the SGLT2-Is: Does the addition of GLP-1 RA improve cardiometabolic risk and outcomes in diabetic patients
If injections arent your thing, Rybelsus offers an alternative as the only oral tablet in the GLP-1 category
